
TG Therapeutics Inc
NASDAQ:TGTX

Intrinsic Value
The intrinsic value of one
TGTX
stock under the Base Case scenario is
34.92
USD.
Compared to the current market price of 39.3 USD,
TG Therapeutics Inc
is
Overvalued by 11%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
TG Therapeutics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
TG Therapeutics Inc
Balance Sheet Decomposition
TG Therapeutics Inc
Current Assets | 566.4m |
Cash & Short-Term Investments | 311m |
Receivables | 129.2m |
Other Current Assets | 126.2m |
Non-Current Assets | 11.3m |
Long-Term Investments | 808k |
PP&E | 7.2m |
Other Non-Current Assets | 3.4m |
Free Cash Flow Analysis
TG Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
TG Therapeutics Inc
Revenue
|
386.4m
USD
|
Cost of Revenue
|
-48.6m
USD
|
Gross Profit
|
337.8m
USD
|
Operating Expenses
|
-278m
USD
|
Operating Income
|
59.8m
USD
|
Other Expenses
|
-20.7m
USD
|
Net Income
|
39.2m
USD
|
TGTX Profitability Score
Profitability Due Diligence
TG Therapeutics Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Score
TG Therapeutics Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
TGTX Solvency Score
Solvency Due Diligence
TG Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Score
TG Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TGTX Price Targets Summary
TG Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
TGTX
is 43.35 USD
with a low forecast of 11.11 USD and a high forecast of 57.75 USD.
Dividends
Current shareholder yield for TGTX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
TGTX
stock under the Base Case scenario is
34.92
USD.
Compared to the current market price of 39.3 USD,
TG Therapeutics Inc
is
Overvalued by 11%.